Pre-Activity Questions
*
*
Please use the scale: 1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=Extremely confident, N/A=Not within the scope of my practice
12345N/A
Manage patients with resectable GC appropriately with adjuvant therapies using a multidisciplinary approach.
Use systemic therapies and targeted therapies in the first- or second-line setting appropriately in managing patients with GC.
Evaluate the mechanisms of action, safety, and efficacy of currently available and emerging targeted GC therapies.
*
*
Please use the scale: 1=Never, 2=Infrequently, 3=Sometimes, 4=Frequently, 5=Always, N/A=Not within the scope of my practice
12345N/A
Determine HER2 status in patients with advanced or metastatic GC prior to initiating first-line therapy?
Use ramucirumab, either alone or in combination with docetaxel, as a second-line therapy in your patients with advanced or metastatic GC?